解偶联蛋白与肿瘤

摘要/Abstract

摘要：

解偶联蛋白(UCP)属于线粒体内膜上的线粒体载体蛋白家族,主要包括UCP1、UCP2和UCP3等。研究表明,UCP通过脂质褐变过程参与恶性肿瘤的发生发展。肿瘤细胞分泌锌-α2-糖蛋白刺激过氧化物酶体增殖物激活受体,诱导脂质褐变并表达UCP1,促进肿瘤的生长。磷脂酶C样蛋白1可上调UCP1表达,消耗异常脂质,使肿瘤细胞集落形成能力降低,抑制肿瘤的迁移和侵袭。另外,肿瘤抑制因子p53的辅助因子过氧化物酶体增殖物激活受体γ共激活因子-1α和过氧化物酶体增殖物激活受体γ共激活因子-1β能增强p53缺乏的脂肪细胞中UCP1的表达,UCP2的上调有助于肿瘤细胞逃避p53介导的细胞凋亡,激活活性氧系统,增强肿瘤的活力和增殖能力。

关键词:线粒体解偶联蛋白质类,肿瘤,过氧化物酶体增殖物激活受体,过氧化物酶体增殖物激活受体γ共激活因子-1α,磷脂酶C样蛋白1

Abstract:

Uncoupling proteins (UCPs) belongs to the mitochondrial carrier protein family on the mitochondrial inner membrane, mainly including UCP1, UCP2 and UCP3. Studies have shown that UCPs participate in the occurrence and development of malignant tumors through lipid browning. Tumor cells secrete zinc-α2-glycoprotein to stimulate the peroxidosomal proliferator-activated receptor, induce lipid browning and express UCP1, and promote the growth of tumor. Phospholipase C-like 1 upregulates UCP1 expression, consumes abnormal lipids, reduces the ability of tumor cell colony formation, and inhibits tumor migration and invasion. In addition, PGC-1 α and PGC-1 β, the co-factors of tumor suppressor p53, can enhance the expression of UCP1 in p53-deficient adipose cells, and the up-regulation of UCP2 can help tumor cells escape apoptosis mediated by p53, activate the reactive oxygen species system, and enhance the vitality and proliferation of tumors.

Key words:Mitochondrial uncoupling proteins,Neoplasms,Peroxisome proliferator-activated receptors,Peroxisome proliferator-activated receptor γ coactivator-1α,Phospholipase C-like 1

代月宇, 宋启斌, 胡伟国. 解偶联蛋白与肿瘤[J]. 国际肿瘤学杂志, 2020, 47(11): 682-685.

Dai Yueyu, Song Qibin, Hu Weiguo. Uncoupling proteins and tumor[J]. Journal of International Oncology, 2020, 47(11): 682-685.

参考文献25

[1]	Porter C. Quantification of UCP1 function in human brown adipose tissue[J]. Adipocyte, 2017,6(2):167-174. DOI: 10.1080/21623945.2017.1319535. doi:10.1080/21623945.2017.1319535pmid:28453364
[2]	Giatromanolaki A, Balaska K, Kalamida D, et al. Thermogenic protein UCP1 and UCP3 expression in non-small cell lung cancer: relation with glycolysis and anaerobic metabolism[J]. Cancer Biol Med, 2017,14(4):396-404. DOI: 10.20892/j.issn.2095-3941.2017.0089. doi:10.20892/j.issn.2095-3941.2017.0089pmid:29372106
[3]	Ravaud C, Paré M, Yao X, et al. Resveratrol and HIV-protease inhibitors control UCP1 expression through opposite effects on p38 MAPK phosphorylation in human adipocytes[J]. J Cell Physiol, 2020,235(2):1184-1196. DOI: 10.1002/jcp.29032. doi:10.1002/jcp.29032pmid:31294462
[4]	Dodd GT, Decherf S, Loh K, et al. Leptin and insulin act on POMC neurons to promote the browning of white fat[J]. Cell, 2015,160(1-2):88-104. DOI: 10.1016/j.cell.2014.12.022. doi:10.1016/j.cell.2014.12.022pmid:25594176
[5]	Zong WX, Rabinowitz JD, White E. Mitochondria and cancer[J]. Mol Cell, 2016,61(5):667-676. DOI: 10.1016/j.molcel.2016.02.011. doi:10.1016/j.molcel.2016.02.011pmid:26942671
[6]	Alnabulsi A, Cash B, Hu Y, et al. The expression of brown fat-associated proteins in colorectal cancer and the relationship of uncoupling protein 1 with prognosis[J]. Int J Cancer, 2019,145(4):1138-1147. DOI: 10.1002/ijc.32198. doi:10.1002/ijc.32198pmid:30737786
[7]	Aguilar E, Esteves P, Sancerni T, et al. UCP2 Deficiency increases colon tumorigenesis by promoting lipid synjournal and depleting NADPH for antioxidant defenses[J]. Cell Rep, 2019, 28(9):2306-2316.e5. DOI: 10.1016/j.celrep.2019.07.097. doi:10.1016/j.celrep.2019.07.097pmid:31461648
[8]	Yu J, Shi L, Shen X, et al. UCP2 regulates cholangiocarcinoma cell plasticity via mitochondria-to-AMPK signals[J]. Biochem Pharmacol, 2019,166:174-184. DOI: 10.1016/j.bcp.2019.05.017. doi:10.1016/j.bcp.2019.05.017pmid:31085159
[9]	Elattar S, Dimri M, Satyanarayana A. The tumor secretory factor ZAG promotes white adipose tissue browning and energy wasting[J]. FASEB J, 2018,32(9):4727-4743. DOI: 10.1096/fj.201701465RR. doi:10.1096/fj.201701465RRpmid:29570397
[10]	Chen HF, Hsu CM, Huang YS. CPEB2-dependent translation of long 3'-UTR UCP1 mRNA promotes thermogenesis in brown adipose tissue[J]. EMBO J, 2018,37(20):e99071. DOI: 10.15252/embj.201899071. doi:10.15252/embj.201899071pmid:30177570
[11]	Porter C, Herndon DN, Chondronikola M, et al. Human and mouse brown adipose tissue mitochondria have comparable UCP1 function[J]. Cell Metab, 2016,24(2):246-255. DOI: 10.1016/j.cmet.2016.07.004. doi:10.1016/j.cmet.2016.07.004pmid:27508873
[12]	Vaitkus JA, Celi FS. The role of adipose tissue in cancer-associated cachexia[J]. Exp Biol Med (Maywood), 2017,242(5):473-481. DOI: 10.1177/1535370216683282. doi:10.1177/1535370216683282
[13]	Xiong Z, Xiao W, Bao L, et al. Tumor cell "slimming" regulates tumor progression through PLCL1/UCP1-mediated lipid browning[J]. Adv Sci (Weinh), 2019,6(10):1801862. DOI: 10.1002/advs.201801862.
[14]	Lima TI, Guimaraes D, Sponton CH, et al. Essential role of the PGC-1α/PPARβ axis in UCP3 gene induction[J]. J Physiol, 2019,597(16):4277-4291. DOI: 10.1113/jp278006. doi:10.1113/JP278006pmid:31228206
[15]	Villarroya F, Peyrou M, Giralt M. Transcriptional regulation of the uncoupling protein-1 gene[J]. Biochimie, 2017,134:86-92. DOI: 10.1016/j.biochi.2016.09.017. doi:10.1016/j.biochi.2016.09.017pmid:27693079
[16]	Kliewer KL, Ke JY, Tian M, et al. Adipose tissue lipolysis and energy metabolism in early cancer cachexia in mice[J]. Cancer Biol Ther, 2015,16(6):886-897. DOI: 10.4161/15384047.2014.987075. doi:10.4161/15384047.2014.987075pmid:25457061
[17]	Castrejón-Tellez V, Rodríguez-Pérez JM, Pérez-Torres I, et al. The effect of resveratrol and quercetin treatment on PPAR mediated uncoupling protein (UCP-) 1, 2, and 3 expression in visceral white adipose tissue from metabolic syndrome rats[J]. Int J Mol Sci, 2016,17(7):1069. DOI: 10.3390/ijms17071069.
[18]	Muter J, Brighton PJ, Lucas ES, et al. Progesterone-dependent induction of phospholipase C-related catalytically inactive protein 1 (PRIP-1) in decidualizing human endometrial stromal cells[J]. Endocrinology, 2016,157(7):2883-2893. DOI: 10.1210/en.2015-1914.
[19]	Basu S, Gnanapradeepan K, Barnoud T, et al. Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α[J]. Genes Dev, 2018,32(3-4):230-243. DOI: 10.1101/gad.309062.117. doi:10.1101/gad.309062.117pmid:29463573
[20]	Hallenborg P, Fjære E, Liaset B, et al. p53 regulates expression of uncoupling protein 1 through binding and repression of PPARγ coactivator-1α[J]. Am J Physiol Endocrinol Metab, 2016,310(2):E116-E128. DOI: 10.1152/ajpendo.00119.2015. pmid:26578713
[21]	Zhang X, Li CF, Zhang L, et al. TRAF6 Restricts p53 mitochon-drial translocation, apoptosis, and tumor suppression[J]. Mol Cell, 2016,64(4):803-814. DOI: 10.1016/j.molcel.2016.10.002. doi:10.1016/j.molcel.2016.10.002pmid:27818144
[22]	Cordani M, Butera G, Dando I, et al. Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial $O_{2-}$· production in cancer cells [J]. Br J Cancer, 2018,119(8):994-1008. DOI: 10.1038/s41416-018-0288-2. doi:10.1038/s41416-018-0288-2pmid:30318520
[23]	Dando I, Pacchiana R, Pozza ED, et al. UCP2 inhibition induces ROS/Akt/mTOR axis: role of GAPDH nuclear translocation in genipin/everolimus anticancer synergism[J]. Free Radic Biol Med, 2017,113:176-189. DOI: 10.1016/j.freeradbiomed.2017.09.022. doi:10.1016/j.freeradbiomed.2017.09.022pmid:28962872
[24]	Yu J, Shi L, Lin W, et al. UCP2 promotes proliferation and chemoresistance through regulating the NF-κB/β-catenin axis and mitochondrial ROS in gallbladder cancer[J]. Biochem Pharmacol, 2020,172:113745. DOI: 10.1016/j.bcp.2019.113745. doi:10.1016/j.bcp.2019.113745pmid:31811866
[25]	Madreiter-Sokolowski CT, Gyorffy B, Klec C, et al. UCP2 and PRMT1 are key prognostic markers for lung carcinoma patients[J]. Oncotarget, 2017,8(46):80278-80285. DOI: 10.18632/oncotarget.20571. doi:10.18632/oncotarget.20571pmid:29113301

Uncoupling proteins and tumor

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献25

相关文章15

编辑推荐

Metrics

本文评价

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲.血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊.局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[3]	袁健, 黄燕华.Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[4]	陈红健, 张素青.血清miR-24-3p、H2AFX与肝癌患者临床病理特征及术后复发的关系研究[J]. 国际肿瘤学杂志, 2024, 51(6): 344-349.
[5]	郭泽浩, 张俊旺.PFDN及其亚基在肿瘤发生发展中的作用[J]. 国际肿瘤学杂志, 2024, 51(6): 350-353.
[6]	张百红, 岳红云.新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[7]	许凤琳, 吴刚.EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[8]	王盈, 刘楠, 郭兵.抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[9]	张蕊, 褚衍六.基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375.
[10]	高凡, 王萍, 杜超, 褚衍六.肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381.
[11]	王丽, 刘志华, 杨伟洪, 蒋凤莲, 李全泳, 宋浩杰, 鞠文东.ROS1突变肺腺鳞癌合并脑梗死为主要表现的Trousseau综合征1例[J]. 国际肿瘤学杂志, 2024, 51(6): 382-384.
[12]	刘静, 刘芹, 黄梅.基于SMOTE算法的食管癌放化疗患者肺部感染的预后模型构建[J]. 国际肿瘤学杂志, 2024, 51(5): 267-273.
[13]	杨琳, 路宁, 温华, 张明鑫, 朱琳.炎症负荷指数与胃癌临床关系研究[J]. 国际肿瘤学杂志, 2024, 51(5): 274-279.
[14]	王俊毅, 洪楷彬, 纪荣佳, 陈大朝.癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285.
[15]	张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志.宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291.